- Home
- ABNB vs SNY Comparison
ABNB vs SNY Comparison
Compare ABNB & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABNB | SNY |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.3B | 104.5B |
| IPO Year | 2020 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ABNB | SNY |
|---|---|---|
| Price | $166.84 | $42.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 30 | 5 |
| Target Price | ★ $151.93 | $58.00 |
| AVG Volume (30 Days) | ★ 3.9M | 1.9M |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.47% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $12,241,000,000.00 | N/A |
| Revenue This Year | $14.25 | $3.49 |
| Revenue Next Year | $10.05 | $6.10 |
| P/E Ratio | $30.80 | ★ $6.14 |
| Revenue Growth | ★ 10.26 | N/A |
| 52 Week Low | $110.81 | $40.89 |
| 52 Week High | $193.45 | $52.68 |
Technical Indicators
Market Signals| Indicator | ABNB | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 41.02 |
| Support Level | $126.08 | $42.30 |
| Resistance Level | $187.12 | $45.22 |
| Average True Range (ATR) | 4.15 | 0.57 |
| MACD | -2.31 | -0.16 |
| Stochastic Oscillator | 12.38 | 10.21 |
Price Performance
Historical ComparisonAbout ABNB Airbnb Inc.
Airbnb is the world's largest online alternative accommodation travel agency; it also offers booking services for boutique hotels, experiences, and hotel-like services. Airbnb's platform offers over 9 million active accommodation listings. Listings from the company's 5 million-plus hosts are spread over almost every country in the world. In 2025, 42% of revenue was from North America, 39% from Europe, the Middle East, and Africa, 10% from Latin America, and 9% from Asia-Pacific. Transaction fees for online bookings account for all its revenue.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.